SCHEMBL30622938

SCHEMBL30622938

C[C@@H]1Cn2nc(-c3ccc(Cl)cc3F)c(-c3ccncc3)c2CN1C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK3 Q9Y572 1/20 0.37
▸ USP30 Q70CQ3 2/20 0.36
▸ BCHE P06276 1/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP3A5 P20815 2/20 0.36
▸ RORC P51449 2/20 0.35
▸ MAP4K4 O95819 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ FRK P42685 1/20 0.34
▸ MAPK9 P45984 1/20 0.34
▸ CSNK1A1 P48729 1/20 0.34
▸ CSNK1D P48730 1/20 0.34
▸ MINK1 Q8N4C8 1/20 0.34
▸ APP P05067 1/20 0.33
▸ GHSR Q92847 1/20 0.33
▸ KCNK3 O14649 2/20 0.33
▸ KCNK9 Q9NPC2 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ P2RX7 Q99572 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645141 1.00 RIPK3 (0.37) RIPK3USP30BCHECYP3A4CYP3A5
SCHEMBL30622909 1.00 RIPK3 (0.37) RIPK3USP30BCHECYP3A4CYP3A5
SCHEMBL30622871 0.89 CPS1 (0.39) USP30MAP4K4PRKACAGHSR
SCHEMBL30622778 0.89 NR1H2 (0.37) USP30APPGHSR
SCHEMBL26645433 0.88 BCHE (0.39) RIPK3BCHEMAP4K4EGFRPRKACA
SCHEMBL26645193 0.88 BCHE (0.39) RIPK3BCHEMAP4K4EGFRPRKACA
SCHEMBL26645160 0.88 BCHE (0.39) RIPK3BCHEMAP4K4EGFRPRKACA
SCHEMBL30622927 0.87 KCNK3 (0.41) USP30KCNK3KCNK9
SCHEMBL30622908 0.87 KCNK3 (0.41) USP30KCNK3KCNK9
SCHEMBL30622395 0.85 BCHE (0.37) RIPK3BCHEMAP4K4EGFRPRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback